About Us
Medicine Beyond Borders
Dr. Ashleys Limited
Dr. Ashleys Limited, a global pharmaceutical company, develops, manufactures, and markets Active Pharmaceutical Ingredients (“API”) Orphan Drugs and provides Contract Development and Manufacturing Organization (CDMO) to other pharmaceutical companies. The company makes over 85 products focusing on Cancer medicine, Anti-malaria, HIV-AIDS medicine, COVID-19, and others. The company markets its product to over 80 countries via a network of over 100 distributors and 200 pharmaceutical companies in Europe, Africa, the Middle East, India, and Southeast Asia. Dr Ashley was founded in 2012 with the promise of delivering life-saving drugs to hard-to-reach places while remaining profitable.
Oncology (Cancer)
Hormonal Therapies
Antibiotics (Bacterial Infections)
Cardiovascular Diseases
Neurological Disorders
Antiviral Treatments
At Dr. Ashleys, our diverse, multilingual team leverages global cultural insights to foster innovation and inclusivity, enhancing client connections with empathy and understanding.
Locations
EU – Riga Latvia
Office Address
Aptiekas iela 7, Riga LV 1005 Latvija
Email Address
Phone Number
USA – Austin TX
Office Address
111 Congress Avenue, Suite 500, Austin, Texas 78701
Email Address
Phone Number
Hong Kong
Office Address
Unit No 1504, 15th Floor Peninsula Square, 18 Sung On Street, Hung Hom Kowloon Hong Kong Sar
Email Address
Phone Number
Cayman Islands
Office Address
4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands.
Email Address
Phone Number
Dr Kanans Visvanats FRSC / Dr. Kanans
Founder Executive Chairman
Dr. Kanans Visvanats FRSC, a distinguished leader in pharmaceutical manufacturing, has made significant contributions to the industry and society. Growing up in India as the son of a successful pharmaceutical manufacturer, he was destined to make a global impact. With a degree in Chemical Engineering, Dr. Kanans revolutionized manufacturing processes for generic and patented drugs, significantly reducing costs and improving delivery systems. His breakthrough in lowering the manufacturing cost of Malaria treatment has led to the distribution of millions of low-cost doses in critical regions. Dr. Kanans filed for 15 patents over his career. He is an esteemed member of the Royal Society of Chemistry, he has received numerous international awards, including the Albert Schweitzer Award in Medicine and the Global Icon Award. As a Garwood Fellow at UC Berkeley and a Member of the Council at the Institute of Economics of the Latvian Academy of Sciences, Dr. Kanans continues to influence the fields of academic research, economics, and entrepreneurship.
